Technical Analysis for ALNA - Allena Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 13.38 2.92% 0.38
ALNA closed up 2.92 percent on Friday, June 22, 2018, on 7.16 times normal volume.

Earnings due: Jun 26

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Flat
See historical ALNA trend table...

Date Alert Name Type % Chg
Jun 22 Volume Surge Other 0.00%
Jun 20 Outside Day Range Expansion 0.60%
Jun 19 Narrow Range Bar Range Contraction -0.37%
Jun 19 NR7 Range Contraction -0.37%
Jun 15 NR7 Range Contraction -1.40%
Jun 15 Inside Day Range Contraction -1.40%
Jun 14 Lizard Bullish Bullish Day Trade Setup -1.11%
Jun 14 Doji - Bullish? Reversal -1.11%
Jun 14 Lower Bollinger Band Touch Weakness -1.11%
Jun 14 Oversold Stochastic Weakness -1.11%

Older signals for ALNA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Allena Pharmaceuticals, Inc. is a United States-based specialty biopharmaceutical company. The Company is focused on developing and commercializing non-systemic oral protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Its lead product candidate, ALLN-177, is in an ongoing Phase II clinical trial and is being developed for the chronic management of hyperoxaluria and kidney stones. ALLN-177 is an orally administered, recombinant oxalate-degrading enzyme. ALLN-177 targets oxalate in the gastrointestinal (GI) tract to reduce the burden of both dietary and endogenously produced oxalate. ALLN-177 has the potential to decrease the oxalate available systemically for deposition as calcium oxalate crystals or stones in the kidneys, as well as to reduce the incidence of calcium oxalate related complications. Its technological approach enables the design and development of oral protein therapies that remain in the GI tract.
Is ALNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.56
52 Week Low 6.13
Average Volume 123,826
200-Day Moving Average 0.0
50-Day Moving Average 14.6
20-Day Moving Average 13.9745
10-Day Moving Average 13.418
Average True Range 0.8734
ADX 34.47
+DI 10.79
-DI 21.59
Chandelier Exit (Long, 3 ATRs ) 13.5098
Chandelier Exit (Short, 3 ATRs ) 15.1302
Upper Bollinger Band 15.4044
Lower Bollinger Band 12.5446
Percent B (%b) 0.29
BandWidth 20.464417
MACD Line -0.402
MACD Signal Line -0.3163
MACD Histogram -0.0857
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.76
Resistance 3 (R3) 14.74 14.25 14.53
Resistance 2 (R2) 14.25 13.90 14.27 14.45
Resistance 1 (R1) 13.82 13.68 14.04 13.84 14.38
Pivot Point 13.33 13.33 13.44 13.35 13.33
Support 1 (S1) 12.90 12.98 13.12 12.92 12.38
Support 2 (S2) 12.41 12.76 12.43 12.31
Support 3 (S3) 11.98 12.41 12.23
Support 4 (S4) 12.00